T. L. Terry, Extreme prematurity and fibroplastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report, Am J Ophthalmol, vol.25, pp.203-204, 1942.

J. Chen and L. E. Smith, Retinopathy of prematurity, Angiogenesis, vol.10, pp.133-140, 2007.

H. A. Mintz-hittner, K. A. Kennedy, A. Z. Chuang, . Beat-rop-cooperative, and . Group, Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity, N Engl J Med, vol.364, pp.603-615, 2011.

J. S. Penn, B. L. Tolman, and M. M. Henry, Oxygeninduced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization, Invest Ophthalmol Vis Sci, vol.35, pp.3429-3435, 1994.

L. E. Smith, E. Wesolowski, A. Mclellan, S. K. Kostyk, D. 'amato et al., Oxygen-induced retinopathy in the mouse, Invest Ophthalmol Vis Sci, vol.35, pp.101-111, 1994.

P. Sapieha, J. S. Joyal, J. C. Rivera, E. Kermorvant-duchemin, F. Sennlaub et al., Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life, J Clin Invest, vol.120, pp.3022-3032, 2010.

P. Sapieha, D. Hamel, Z. Shao, J. C. Rivera, K. Zaniolo et al., Proliferative retinopathies: angiogenesis that blinds, Int J Biochem Cell Biol, vol.42, pp.5-12, 2010.

N. Ashton, Retinal angiogenesis in the human embryo, Br Med Bull, vol.26, pp.103-106, 1970.

C. Pollan, Retinopathy of prematurity: an eye toward better outcomes, Neonatal Netw, vol.28, pp.93-101, 2009.

E. A. Palmer, J. T. Flynn, R. J. Hardy, D. L. Phelps, C. L. Phillips et al., Incidence and early course of retinopathy of prematurity. The Cryotherapy for retinopathy of Prematurity Cooperative Group, Ophthalmology, vol.98, pp.1628-1640, 1991.

R. M. Siatkowski, V. Dobson, G. E. Quinn, C. G. Summers, E. A. Palmer et al., Severe visual impairment in children with mild or moderate retinal residua following regressed threshold retinopathy of prematurity, J AAPOS, vol.11, pp.148-152, 2007.

A. B. Fulton, R. M. Hansen, R. A. Petersen, and D. K. Vanderveen, The rod photoreceptors in retinopathy of prematurity: an electroretinographic study, Arch Ophthalmol, vol.119, pp.499-505, 2001.

A. L. Dorfman, N. Cuenca, I. Pinilla, S. Chemtob, and P. Lachapelle, Immunohistochemical evidence of synaptic retraction, cytoarchitectural remodeling, and cell death in the inner retina of the rat model of oxygen-induced retinopathy (OIR), Invest Ophthalmol Vis Sci, vol.52, pp.1693-1708, 2011.

Z. Shao, A. L. Dorfman, S. Seshadri, M. Djavari, E. Kermorvant-duchemin et al., Choroidal involution is a key component of oxygen induced retinopathy, Invest Ophthalmol Vis Sci, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02983694

T. R. Vrabec, J. A. Mcnamara, R. C. Eagle, and W. Tasman, Cryotherapy for retinopathy of prematurity: a histopathologic comparison of a treated and untreated eye, Ophthalmic Surg, vol.25, pp.38-41, 1994.

I. Akkoyun, S. Oto, G. Yilmaz, B. Gurakan, A. Tarcan et al., Risk factors in the development of mild and severe retinopathy of prematurity, J AAPOS, vol.10, pp.449-453, 2006.

D. W. Milligan, Failure of autoregulation and intraventricular haemorrhage in preterm infants, Lancet, vol.1, pp.896-898, 1980.

P. Hardy, D. Abran, D. Y. Li, H. Fernandez, D. R. Varma et al., Free radicals in retinal and choroidal blood flow autoregulation in the piglet: interaction with prostaglandins, vol.35, pp.580-591, 1994.

P. Hardy, D. Lamireau, X. Hou, I. Dumont, D. Abran et al., Major role for neuronal NO synthase in curtailing choroidal blood flow autoregulation in newborn pig, J Appl Physiol, vol.91, pp.1655-1662, 2001.

D. Checchin, X. Hou, P. Hardy, D. Abran, T. Najarian et al., Chemtob S: PGE2-mediated eNOS induction in prolonged hypercapnia, Invest Ophthalmol Vis Sci, vol.43, pp.1558-1566, 2002.

J. M. Holmes, S. Zhang, D. A. Leske, and W. L. Lanier, Carbon dioxide-induced retinopathy in the neonatal rat, Curr Eye Res, vol.17, pp.608-616, 1998.

T. Alon, I. Hemo, A. Itin, J. Pe'er, and J. Stone, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity, Nat Med, vol.1, pp.1024-1028, 1995.

J. Chen, K. M. Connor, C. M. Aderman, and L. E. Smith, Erythropoietin deficiency decreases vascular stability in mice, J Clin Invest, vol.118, pp.526-533, 2008.

. Rivera, Neonatology, vol.100, pp.343-353, 2011.

A. Hellstrom, C. Perruzzi, M. Ju, E. Engstrom, A. L. Hard et al., Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity, Proc Natl Acad Sci, vol.98, pp.5804-5808, 2001.

K. M. Connor, J. P. Sangiovanni, C. Lofqvist, C. M. Aderman, J. Chen et al., Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis, Nat Med, vol.13, pp.868-873, 2007.

P. Hardy, K. G. Peri, I. Lahaie, D. R. Varma, and S. Chemtob, Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs, Circ Res, vol.79, pp.504-511, 1996.

P. Hardy, M. Beauchamp, F. Sennlaub, F. Gobeil, L. Tremblay et al., New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy, Prostaglandins Leukot Essent Fatty Acids, vol.72, pp.301-325, 2005.

M. Balazy and S. Chemtob, Trans-arachidonic acids: new mediators of nitro-oxidative stress, Pharmacol Ther, vol.119, pp.275-290, 2008.

D. Abran, D. R. Varma, and S. Chemtob, Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides, Am J Physiol, vol.268, pp.628-632, 1995.

M. H. Beauchamp, F. Sennlaub, G. Speranza, F. Gobeil, D. Checchin et al., Redox dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy, Free Radic Biol Med, vol.37, pp.1885-1894, 2004.

D. Checchin, F. Sennlaub, M. Sirinyan, S. Brault, T. Zhu et al., Hypercapnia prevents neovascularization via nitrative stress, vol.40, pp.543-553, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00150827

X. Gu, A. B. El-remessy, S. E. Brooks, M. Al-shabrawey, N. T. Tsai et al., Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite, Am J Physiol Cell Physiol, vol.285, pp.546-554, 2003.

S. E. Brooks, X. Gu, S. Samuel, D. M. Marcus, M. Bartoli et al., Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice, Invest Ophthalmol Vis Sci, vol.42, pp.222-228, 2001.

E. Kermorvant-duchemin, F. Sennlaub, M. Sirinyan, S. Brault, G. Andelfinger et al., Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration, Nat Med, vol.11, pp.1339-1345, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00150825

J. S. Penn, B. L. Tolman, and L. E. Bullard, Effect of a watersoluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity, Free Radic Biol Med, vol.22, pp.977-984, 1997.

M. R. Niesman, K. A. Johnson, and J. S. Penn, Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity, Neurochem Res, vol.22, pp.597-605, 1997.

M. H. Beauchamp, A. K. Martinez-bermudez, F. Gobeil, A. M. Marrache, X. Hou et al., Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy, J Appl Physiol, vol.90, pp.2279-2288, 2001.

X. Hou, F. Gobeil, P. K. Speranza, G. Marrache, A. M. Lachapelle et al., Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels, Stroke, vol.31, pp.516-524, 2000.

C. M. Zghibeh, R. Gopal, V. Poff, C. D. Falck, J. R. Balazy et al., Determination of trans-arachidonic acid isomers in human blood plasma, Anal Biochem, vol.332, pp.137-144, 2004.

F. Snyder, Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators, Am J Physiol, vol.259, pp.697-708, 1990.

M. H. Beauchamp, A. M. Marrache, X. Hou, F. Gobeil, S. G. Bernier et al., Plateletactivating factor in vasoobliteration of oxygen-induced retinopathy, Invest Ophthalmol Vis Sci, vol.43, pp.3327-3337, 2002.

X. Hou, F. Gobeil, A. M. Marrache, C. Quiniou, S. Brault et al., Increased platelet-activating factor induced periventricular brain microvascular constriction associated with immaturity, Am J Physiol Regul Integr Comp Physiol, vol.284, pp.928-935, 2003.

S. Brault, F. Gobeil, A. Fortier, J. C. Honoré, J. S. Joyal et al., Lysophosphatidic acid induces endothelial cell death by modulating the redox environment, Am J Physiol Regul Integr Comp Physiol, vol.292, pp.1174-1183, 2007.

J. P. Liu, J. Baker, A. S. Perkins, and E. J. Robertson, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (IGF-1R), Cell, vol.75, pp.59-72, 1993.

K. Langford, K. Nicolaides, and J. P. Miell, Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy, Hum Reprod, vol.13, pp.1389-1393, 1998.

J. D. Lineham, R. M. Smith, G. W. Dahlenburg, R. A. King, R. R. Haslam et al., Circulating insulin-like growth factor I levels in newborn premature and full term infants followed longitudinally, Early Hum Dev, vol.13, pp.37-46, 1996.

L. Smith, Essential role of growth hormone in ischemia-induced retinal neovascularization, Science, vol.276, pp.1706-1709, 1997.

L. E. Smith, W. Shen, C. Perruzzi, S. Soker, F. Kinose et al., Regulation of vascular endothelial growth factordependent retinal neovascularization by insulin-like growth factor-1 receptor, Nat Med, vol.5, pp.1390-1395, 1999.

A. Hellstrom, E. Engstrom, A. L. Hard, K. Albertsson-wikland, B. Carlsson et al., Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth, Pediatrics, vol.112, pp.1016-1020, 2003.

C. Lofqvist, J. Chen, K. M. Connor, A. C. Smith, C. M. Aderman et al., IGFBP3 suppresses retinopathy through suppression of oxygeninduced vessel loss and promotion of vascular regrowth, Proc Natl Acad Sci, vol.104, pp.10589-10594, 2007.

I. Hansen-pupp, E. Engstrom, A. Niklasson, A. C. Berg, V. Fellman et al., Fresh frozen plasma as a source of exogenous insulin-like growth factor I in the extremely preterm infant, J Clin Endocrinol Metab, vol.94, pp.477-482, 2009.

C. Lofqvist, A. Niklasson, E. Engstrom, L. E. Friberg, C. Camacho-hubner et al., A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants, Pediatr Res, vol.65, pp.574-579, 2009.

S. Vanhaesebrouck, H. Daniels, L. Moons, C. Vanhole, P. Carmeliet et al., Oxygen-induced retinopathy in mice: amplification by neonatal IGF-1 deficit and attenuation by IGF-1 administration, Pediatr Res, vol.65, pp.307-310, 2009.

H. Q. Miao, S. Soker, L. Feiner, J. L. Alonso, J. A. Raper et al., Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165, J Cell Biol, vol.146, pp.233-242, 1999.

M. Klagsbrun and A. Eichmann, A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis, Cytokine Growth Factor Rev, vol.16, pp.535-548, 2005.

, Understanding Retinopathy of Prematurity: Update on, Pathogenesis Neonatology, vol.100, pp.343-353, 2011.

J. S. Joyal, N. Sitaras, F. Binet, J. C. Rivera, A. Stahl et al., Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A, Blood, vol.117, pp.6024-6035, 2011.

Y. Fukushima, M. Okada, H. Kataoka, M. Hirashima, Y. Yoshida et al., Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice, J Clin Invest, vol.121, pp.1974-1985, 2011.

R. F. Gariano and T. W. Gardner, Retinal angiogenesis in development and disease, Nature, vol.438, pp.960-966, 2005.

P. Sapieha, M. Sirinyan, D. Hamel, K. Zaniolo, J. S. Joyal et al., The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis, Nat Med, vol.14, pp.1067-1076, 2008.

W. He, F. J. Miao, D. C. Lin, R. T. Schwandner, Z. Wang et al., Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors, Nature, vol.429, pp.188-193, 2004.

B. G. Sood, A. Madan, S. Saha, D. Schendel, P. Thorsen et al., NICHD Neonatal Research Network: Perinatal systemic inflammatory response syndrome and retinopathy of prematurity, Pediatr Res, vol.67, pp.394-400, 2010.

T. Sato, S. Kusaka, H. Shimojo, and T. Fujikado, Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity, Ophthalmology, vol.116, pp.2165-2169, 2009.

R. N. Dubois, S. B. Abramson, L. Crofford, R. A. Gupta, L. S. Simon et al., Cyclooxygenase in biology and disease, FASEB J, vol.12, pp.1063-1073, 1998.

F. Sennlaub, F. Valamanesh, A. Vazquez-tello, A. M. El-asrar, D. Checchin et al., Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy, Circulation, vol.108, pp.198-204, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00150824

D. Weitz, H. Weintraub, E. Fisher, and A. Z. Schwartzbard, Fish oil for the treatment of cardiovascular disease, Cardiol Rev, vol.18, pp.258-263, 2010.

K. Mayurasakorn, J. J. Williams, V. S. Ten, and R. J. Deckelbaum, Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia, Curr Opin Clin Nutr Metab Care, vol.14, pp.158-167, 2011.

B. G. Jeffrey, H. S. Weisinger, M. Neuringer, and D. C. Mitchell, The role of docosahexaenoic acid in retinal function, Lipids, vol.36, pp.859-871, 2001.

J. P. Sangiovanni, S. Parra-cabrera, G. A. Colditz, C. S. Berkey, and J. T. Dwyer, Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants, Pediatrics, vol.105, pp.1292-1298, 2000.

P. Sapieha, A. Stahl, J. Chen, M. R. Seaward, K. L. Willett et al., 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of -3 polyunsaturated fatty acids, Sci Transl Med, vol.3, pp.69-81, 2011.

D. Pawlik, R. Lauterbach, and E. Turyk, Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants, Pediatrics, vol.127, pp.223-228, 2011.

, Chew EY: Fatty acids and retinopathy, N Engl J Med, vol.364, pp.1970-1971, 2011.

J. A. Micieli, M. Surkont, and A. F. Smith, A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity, Am J Ophthalmol, vol.148, pp.536-543, 2009.

M. L. Chen, L. Guo, L. E. Smith, C. E. Dammann, and O. Dammann, High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis, Pediatrics, vol.125, pp.1483-1492, 2010.

T. N. Raju, P. Langenberg, V. Bhutani, and G. E. Quinn, Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials, J Pediatr, vol.131, pp.844-850, 1997.

T. M. Berger, N. Rifai, M. E. Avery, and B. Frei, Vitamin C in premature and full-term human neonates, Redox Rep, vol.2, pp.257-262, 1996.

A. Otani, K. Kinder, K. Ewalt, F. J. Otero, P. Schimmel et al., Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis, Nat Med, vol.8, pp.1004-1010, 2002.